Min Lee founded IPMD, Inc. in January 2012. He recognizes the enormous potential in the point-of-care device’s ability to simultaneously detect both the presence of tuberculosis and its drug resistances. He is the leading inventor to patent the Point-of-Care Medical Device and its revolutionary disposable cartridge system. Min Lee holds a Bachelor’s degree in Economics from UC Berkeley.

Dr. Moon is the one of key developers of IPMDx TB, the POC medical device prototype, built both its hardware and software, applied LAMP and PCR reactions, and implemented analysis of results via image processing. Dr. Moon earned his Ph.D. in Electrical Engineering at the University of Washington, Seattle, WA.

Matthew Lee has biochemistry research experience under Dr. Shahriar Yaghoubi PhD from UC San Francisco and CellSight Technologies, where he has been involved in developing and testing anticancer agents, reporter probes, and reporter genes. This experience has contributed to IPMD's patent development regarding aptamers, biomarker discovery, and biochip design. Lee holds a Bachelor’s degree in Biomedical Engineering from UC San Diego.

P. Scott Alexander is responsible for providing the LAMP Reaction Protocols including primer sets necessary for the detection of TB, MDR-TB, and XDR-TB. He has Molecular Biology and Bio-Informatics Degree from Indiana Universtiy.

He is also an expert on FDA regulations and insurance Coding System.